yinhsing
Botanicalexperimental
Clinical trial activity
41 trials · 56 clinical orgs · 0 marketing orgs
Phase 1
13
Phase 2
21
Phase 3
9
Phase 4
6
Earliest trial started Sep 1, 1999 (NCT00010842)
Timeline
Indications
Approved for
Studied for
- Allergy and Immunology · Phase 4
- Alzheimer Disease · Phase 4
- Asthma · Phase 1/Phase 2
- Blood Pressure · Early Phase 1
- Breast Neoplasms · Phase 3
- Carotid Stenosis · Phase 3
- Cerebrovascular Disorders · Phase 4
- Cognition · Early Phase 1
- Cognition Disorders · Phase 4
- Cognitive Dysfunction · Phase 4
- Coronary Artery Disease · Phase 4
- Dementia · Phase 3
- Dementia, Vascular · Phase 4
- Depression · Phase 1
- Diabetes Mellitus, Type 2 · Phase 4
- Diabetic Retinopathy · Phase 1
- Drug-Related Side Effects and Adverse Reactions · Phase 3
- Fetal Growth Retardation · Phase 2
- Glaucoma · Phase 3
- Glaucoma, Open-Angle · Phase 2
- Healthy Volunteers · Phase 4
- Hearing Loss · Phase 2
- HIV Infections · Phase 1
- Intermittent Claudication · Phase 1/Phase 2
- Memory Disorders · Phase 3
- Memory, Short-Term · Phase 1/Phase 2
- Multiple Sclerosis · Phase 2
- Osteoarthritis, Knee · Phase 2
- Ototoxicity · Phase 2
- Peripheral Vascular Diseases · Phase 1/Phase 2
- Raynaud Disease · Phase 2
- Retinitis Pigmentosa · Early Phase 1
- Sexual Dysfunctions, Psychological · Phase 2
- Tinea Pedis · Phase 1
- Vestibular Neuronitis · Phase 3
- Vitiligo · Phase 1
Mechanism of action
- Unspecified targetAntioxidant
antioxidant
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- adiantifolia
- baiguo
- bai guo ye
- fossil tree
- gingko biloba
- ginkgo biloba
- ginkgo biloba
- ginkgo folium
- ginko biloba
- herba ginkgo biloba
- japanese silver apricot
- kew tree
- maidenhair tree
- pei go su ye
- salisburia adiantifolia
- yen xing
- yinhsing
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03125551 | N/A | Jun 1, 2017 | University of Pretoria |
| NCT03090516 | Phase 2/Phase 3 (Phase 3) | Aug 10, 2016 | Nanjing Medical University |
| NCT02984813 | Phase 1 | Apr 1, 2016 | Icahn School of Medicine at Mount Sinai, The New York Eye & Ear Infirmary |
| NCT02882438 | Phase 1 | Jan 1, 2016 | Al Azhar University |
| NCT02604381 | Phase 2 | Nov 1, 2015 | Joint Health Wellness Group, LLC., KGK Science Inc. |
| NCT03004508 | Phase 2 | Jul 1, 2015 | Indena S.p.A, Vita-Salute University of Milano. Italy |
| NCT02465749 | Early Phase 1 (Phase 1) | May 1, 2015 | Guangzhou Jeeyor Medical Research Co.,Ltd., Southern Medical University, Sun Yat-Sen University |
| NCT02982603 | Phase 4 | Jan 1, 2015 | Peking University |
| NCT01663467 | N/A | Sep 1, 2014 | Seoul National University, Soonchunhyang University |
| NCT02133989 | Phase 3 | Jun 1, 2014 | Sungkyunkwan University, Yuyu Pharma, Inc. |
| NCT02425436 | Phase 2 | May 1, 2014 | Assiut University |
| NCT02386852 | Early Phase 1 (Phase 1) | Mar 1, 2014 | Sunway University |
| NCT02098330 | Phase 3 | Mar 1, 2014 | University of Ulsan |
| NCT02026479 | N/A | Jan 1, 2014 | Peking University |
| NCT01637168 | Phase 3 | Nov 1, 2013 | EMS S/A |
| NCT01524380 | N/A | Sep 1, 2011 | Peking University |
| NCT02376114 | Phase 2 | Aug 1, 2011 | University of Montreal |
| NCT01672359 | N/A | May 1, 2011 | Standard Process Inc., University of Miami |
| NCT01246804 | Phase 1 | Nov 1, 2010 | Merck, Radboud University |
| NCT01046292 | Phase 4 | Jan 1, 2010 | University of Bern |
Showing 20 of 41 trials
Page 1 / 3
Organizations
Research & Development (56)
56 organizations
Page 1 / 3